Logo 1 Logo 2

Investigational Drug Details

Drug ID: D060
Drug Name: Indinavir
Synonyms:
Type: small molecule
DrugBank ID: DB00224
DrugBank Description: A potent and specific HIV protease inhibitor that appears to have good oral bioavailability. [PubChem]
PubChem ID: 5362440
CasNo: 150378-17-9
Repositioning for NAFLD: Yes
SMILES: CC(C)(C)NC(=O)[C@@H]1CN(CC2=CN=CC=C2)CCN1C[C@@H](O)C[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H]1[C@H](O)CC2=CC=CC=C12
Structure:
InChiKey: CBVCZFGXHXORBI-PXQQMZJSSA-N
Molecular Weight: 613.7895
DrugBank Targets: Human immunodeficiency virus type 1 protease
DrugBank MoA: Indinavir inhibits the HIV viral protease enzyme which prevents cleavage of the gag-pol polyprotein, resulting in noninfectious, immature viral particles.
DrugBank Pharmacology: Indinavir is a protease inhibitor with activity against Human Immunodeficiency Virus Type 1 (HIV-1). Protease inhibitors block the part of HIV called protease. HIV-1 protease is an enzyme required for the proteolytic cleavage of the viral polyprotein precursors into the individual functional proteins found in infectious HIV-1. Indinavir binds to the protease active site and inhibits the activity of the enzyme. This inhibition prevents cleavage of the viral polyproteins resulting in the formation of immature non-infectious viral particles. Protease inhibitors are almost always used in combination with at least two other anti-HIV drugs.
DrugBank Indication: Indinavir is an antiretroviral drug for the treatment of HIV infection.
Targets:
Therapeutic Category:
Clinical Trial Progress:
Latest Progress: